Company Description Osprey Medical’s proprietary technologies are designed to reduce the amount of dye (contrast) injected during commonly performed heart procedures to protect the kidneys from damage known as contrast induced nephropathy (CIN). Dye is routinely used to x-ray the heart during angioplasty and stenting procedures. Patients at high risk of CIN often have pre-existing chronic kidney disease.